Patents by Inventor Ilya Zhivkovich

Ilya Zhivkovich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210205334
    Abstract: A method and composition for preserving muscle mass and function by increasing muscle protein synthesis and/or decreasing muscle protein degradation in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at least two of an essential amino acid, an amino acid derivative, and a nitrogenous organic acid. In a particular embodiment, the protein building composition comprises leucine, L-carnitine, and creatine. The protein building composition can decrease TNF-? and increase mTOR expression in muscle.
    Type: Application
    Filed: January 8, 2021
    Publication date: July 8, 2021
    Inventors: Aouatef Bellamine, Ilya Zhivkovich, Ulla Freitas
  • Patent number: 10888571
    Abstract: A method and composition for preserving muscle mass and function by increasing muscle protein synthesis and/or decreasing muscle protein degradation in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at least two of an essential amino acid, an amino acid derivative, and a nitrogenous organic acid. In a particular embodiment, the protein building composition comprises leucine, L-carnitine, and creatine. The protein building composition can decrease TNF-? and increase mTOR expression in muscle.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: January 12, 2021
    Assignee: Lonza Consumer Health Inc.
    Inventors: Aouatef Bellamine, Ilya Zhivkovich, Ulla Freitas
  • Publication number: 20170173050
    Abstract: A method and composition for preserving muscle mass and function by increasing muscle protein synthesis and/or decreasing muscle protein degradation in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at least two of an essential amino acid, an amino acid derivative, and a nitrogenous organic acid. In a particular embodiment, the protein building composition comprises leucine, L-carnitine, and creatine. The protein building composition can decrease TNF-? and increase mTOR expression in muscle.
    Type: Application
    Filed: December 16, 2016
    Publication date: June 22, 2017
    Inventors: Aouatef Bellamine, Ilya Zhivkovich, Ulla Freitas